BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsiao HJ, Wu CT, Huang JL, Chiu CH, Huang YC, Lin JJ, Huang IA, Chan OW, Chou IJ, Hsia SH. Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit. BMC Pediatr 2015;15:85. [PMID: 26184113 DOI: 10.1186/s12887-015-0387-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Singh AK, Osman AS, Woodiga SA, White P, Mahan JD, King SJ. Defining the role of pneumococcal neuraminidases and O-glycosidase in pneumococcal haemolytic uraemic syndrome. J Med Microbiol 2016;65:975-84. [PMID: 27469261 DOI: 10.1099/jmm.0.000322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
2 Zurawska JH, Romney MG, Wong H, Wang H, Ayas NT, Hoang LMN, Stefanovic A, Doyle P, Dhingra V, Dodek PM. Outcomes of Critically Ill Patients Who Have Serotype 5 Invasive Pneumococcal Disease. J Intensive Care Med 2020;35:63-7. [PMID: 28901208 DOI: 10.1177/0885066617728895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Lee M, Kuo K. The clinical implication of serotype distribution and drug resistance of invasive pneumococcal disease in children: A single center study in southern Taiwan during 2010–2016. Journal of Microbiology, Immunology and Infection 2019;52:937-46. [DOI: 10.1016/j.jmii.2019.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]